logo
ENTITY

Mira Pharmaceuticals (MIRA US)

7
Analysis
Health Care • United States
Mira Pharmaceuticals, Inc. operates as a biotech company. The Company develops prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects such as increased appetite and paranoia. Mira Pharmaceuticals serves customers worldwide.
more
bullish•Mira Pharmaceuticals
•21 Dec 2024 00:00•Issuer-paid

MIRA: IND Application Submitted to FDA

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•20 Dec 2024 00:05•Issuer-paid

MIRA: IND Application Submitted to FDA

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•14 Nov 2024 06:00•Issuer-paid

MIRA: Solid Balance Sheet for Promising Company

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•14 Nov 2024 02:00•Issuer-paid

MIRA: Solid Balance Sheet for Promising Company

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•21 Oct 2024 23:00•Issuer-paid

MIRA: Raising Price Target on Study Results

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x